Advances in stem cell research and therapeutic development

Michele De Luca1, Alessandro Aiuti2,3, Giulio Cossu4

  • 1Center for Regenerative Medicine "Stefano Ferrari", Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy. michele.deluca@unimore.it.

Nature Cell Biology
|June 19, 2019
PubMed

Insights

Few stem cell therapies are proven despite many reports. This review examines advances in stem cell research, clinical applications, and the scientific basis for their use in treating genetic disorders and injuries.

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Clinical Therapeutics

Background:

  • Numerous stem cell treatments are reported for genetic, degenerative disorders, and injuries.
  • However, the number of clinically validated stem cell therapies remains limited.

Purpose of the Study:

  • To review current advances in stem cell research.
  • To identify cell types used in clinical trials or nearing clinical application.
  • To analyze the scientific rationale, methods, and outcomes of stem cell therapies.

Main Methods:

  • Literature review of stem cell research.
  • Analysis of clinical trial data and scientific literature.
  • Evaluation of experimental approaches and results.

Main Results:

  • Identification of stem cell types progressing towards clinical use.
  • Assessment of the scientific evidence supporting current stem cell applications.
  • Discussion of challenges and limitations in stem cell therapy development.

Conclusions:

  • Stem cell therapy development requires rigorous scientific validation.
  • Further research is needed to translate promising stem cell research into proven clinical treatments.
  • Understanding the rationale and caveats is crucial for advancing stem cell applications.

Related Concept Videos

Zygotic Development And Stem Cell Formation01:10

Zygotic Development And Stem Cell Formation

The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
6.6K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K